VOYG — what changed in the latest 10-Q
A section-by-section comparison of VOYG's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-04 vs the prior 10-Q · 2026-05-05
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +51 | −33 | ~36 | 77 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~4 | 3 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 2 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +3 | 0 | ~1 | 2 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-04
*% Change not meaningful; non-meaningful changes are defined as greater than absolute value of 200% change or a change from 0%
The increase in net sales for the three months ended June 30, 2026, compared to the three months ended June 30, 2025 was primarily related to an increase in U.S. sales of $8.6 million and partially offset by a decrease in sales in the international market. For a further discussion of the drivers beh…
The increase in net sales for the six months ended June 30, 2026, compared to the six months ended June 30, 2025 was primarily related to an increase in U.S. sales of $10.4 million and partially offset by a decrease in sales in the international market. For a further discussion of the drivers behind…
The increase in costs of sales was primarily due to the increase in total net sales volumes, primarily driven by an increase in U.S. sales volume of $8.6 million and program mix for the three months ended June 30, 2026, compared to the three months ended June 30, 2025.
The increase in costs of sales was primarily due to the increase in total net sales volumes, primarily related to an increase in U.S. sales of $10.4 million and program input costs associated with firm fixed price programs, which experienced an increase in aggregate of $6.4 million more for the six …
Text removed vs the prior filing · source: 10-Q · 2026-05-05
Net loss attributable to noncontrolling interests(1,961)(991)(970)97.9 %
The increase in net sales for the three months ended March 31, 2026, compared to the three months ended March 31, 2025 was primarily related to an increase in U.S. sales of $1.7 million and partially offset by decreases in sales in the international market. For a further discussion of the drivers be…
The increase in costs of sales was primarily due to the increase in sales volumes and program input costs associated with firm fixed price programs, which experienced growth in aggregate of $6.0 million more for the three months ended March 31, 2026, compared to the three months ended March 31, 2025…
The increase in selling, general, and administrative costs was primarily due to the increase in corporate expenses related to headcount growth of $3.2 million along with an increase of stock-based compensation expenses driven by initial public offering awards vesting expenses of $2.4 million for the…
The increase in research and development was primarily due to the increase in Strategic Systems research and development efforts of $3.2 million during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025.
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-04
On May 12, 2026, Matthew Kuta, our President, Co-Founder and Director, adopted a Rule 10b5-1(c) trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 199,807 shares of our Class A common stock. The plan will expire on May 11, 2027, subject to early t…
On May 12, 2026, Margaret Vernal, our Chief Legal Officer, General Counsel and Secretary, adopted a Rule 10b5-1(c) trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 7,937 shares of our Class A common stock. The plan will expire on August 10, 2027…
On May 13, 2026, Matthew Magaña, our President of Space, Defense & National Security, adopted a Rule 10b5-1(c) trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 27,500 shares of our Class A common stock. The plan will expire on August 10, 2027, s…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice